The role of apoptosis in pulmonary fibrosis

Histology and Histopathology

Volumn 19, Issue 3, 2004, Pages 867-881

  Kuwano, Kazuyoshi ^a   Hagimoto, N ^a   Nakanishi, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Epithelium; Fibroblast; Lung injury; Pulmonary fibrosis

Indexed keywords

AMIODARONE; BLEOMYCIN; CAPTOPRIL; COLLAGEN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; LOSARTAN; MONOCROTALINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

APOPTOSIS; CELL DAMAGE; CELL PROLIFERATION; CONNECTIVE TISSUE; CONNECTIVE TISSUE CELL; DISEASE CONTROL; DRUG MECHANISM; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROBLAST; HUMAN; INFLAMMATION; LUNG FIBROSIS; LUNG INJURY; LUNG PARENCHYMA; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SURVIVAL;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL DIVISION; COLLAGEN; CYTOKINES; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FIBROBLASTS; GROWTH SUBSTANCES; HUMANS; INFLAMMATION; LUNG; MODELS, BIOLOGICAL; PULMONARY FIBROSIS;

ANIMALIA;

EID: 3042704101     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (164)

1. Abreu-Martin M.T., Vidrich A., Lynch D.H. and Targan S.R. (1995). Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alfa and ligation of Fas antigen. J. Immunol. 155, 4147-4154.
2. Adamson I.Y., Young L. and Bowden D.H. (1988). Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am. J. Pathol. 130, 377-383.
3. Albertine K.H., Soulier M.F., Wang Z., Ishizaka A., Hashimoto S., Zimmerman G.A., Matthay M.A. and Ware L.B. (2002). Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Pathol. 161, 1783-1796.
4. Albertine K.H. and Plopper C.G. (2002). DNA oxidation or apoptosis: will the real culprit of dna damage in hyperoxic lung injury please stand up? Am. J. Respir. Cell Mol. Biol. 26, 381-383.
5. Barazzone-Argiroffo C., Pagano A., Juge C., Metrailler I., Rochat A., Vesin C. and Donati Y. (2003). Glucocorticoids aggravate hyperoxia-induced lung injury through decreased nuclear factor-kappa B activity. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L197-204.
6. Barazzone C., Donati Y.R., Rochat A.F., Vesin C., Kan C.D., Pache J.C. and Piguet P. F. (1999). Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice. Am. J. Pathol. 154, 1479-1487.
7. Barbas-Filho J.V., Ferreira M.A., Sesso A., Kairalla R.A., Carvalho C.R. and Capelozzi V.L. (2001). Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J. Clin. Pathol. 54, 132-138.
8. Bardales R.H., Xie S.S., Schaefer R.F. and Hsu S.M. (1996). Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am. J. Pathol. 149, 845-852.
9. Behr J., Degenkolb B., Maier K., Braun B., Beinert T., Krombach F., Vogelmeier C. and Fruhmann G. (1995). Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis. Eur. Respir. J. 8, 1286-1292.
10. Behr J., Maier K., Degenkolb B., Krombach F. and Vogelmeier C. (1997). Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am. J. Respir. Crit. Care Med. 156, 1897-1901.
11. Bissonnette N. and Hunting D.J. (1998). p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene 16, 3461-3469.
12. Brunner T., Mogil R.J., LaFace D., Yoo N.J., Mahboubi A., Echeverri F., Martin S.J., Force W.R., Lynch D.H., Ware C.F. and Green D.R. (1995). Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441-444.
13. Cantin A.M., North S.L., Fells G.A., Hubbard R.C. and Crystal R.G. (1987). Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J. Clin. Invest. 79, 1665-1673.
14. Cantin A.M., Hubbard R.C. and Crystal R.G. (1989). Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 139, 370-372.
15. Chen R.H. and Chang T.Y. (1997). Involvement of caspase family proteases in transforming growth factor- beta-induced apoptosis. Cell Growth Differ. 8, 821-827.
16. Chinnaiyan A.M., O'Rourke K., Tewari M. and Dixit V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domainof Fas and initiate apoptosis. Cell 81, 505-512.
17. Coalson J.J. (1982). The ultrastructure of human fibrosing alveolitis. Virchows Arch. Pathol. Anat. Histol. 395, 181-199.
18. Coker R.K., Laurent G.J., Shahzeidi S., Shahzeidi S., Lympany P.A., du Bois R.M., Jeffery P.K. and McAnulty R.J. (1997). Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am. J. Pathol. 150, 981-991.
19. Davis D.W., Weidner D.A., Holian A. and McConkey D.J. (2000). Nitric Oxide - dependent Activation of p53 Suppresses Bleomycin-induced Apoptosis in the Lung. J. Exp. Med. 192, 857-870.
20. Dhein J., Walczak H., Bäumler C., Debatin K.M., and Krammer P.H. (1995). Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438-441.
21. El-Deily W.S., Takashi T., Veluculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kintzler K.W. and Vogelstein B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
22. Franek W.R., Chowdary Y.C., Lin X., Hu M., Miller E.J., Kazzaz J.A., Razzano P., Romashko J. 3rd, Davis J.M., Narula P., Horowitz S., Scott W. and Mantell L.L. (2002). Suppression of nuclear factor-kappa B activity by nitric oxide and hyperoxia in oxygen-resistant cells. J. Biol. Chem. 277, 42694-42700.
23. Fujita T., Maruyama M., Araya J., Sassa K., Kawagishi Y., Hayashi R., Matsui S., Kashii T., Yamashita N., Sugiyama E. and Kobayashi M. (2002). Hydrogen peroxide induces upregulation of Fas in human airway epithelial cells via the activation of PARP-p53 pathway. Am. J. Respir. Cell Mol. Biol. 27, 542-552.
24. Fukuda Y., Ishizaki M., Masuda Y., Kimura G., Kawanami O. and Masugi Y. (1987). The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am. J. Pathol. 126, 171-182.
25. Gaston B., Drazen J.M., Loscalzo J. and Stamler J.S. (1994). The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 149(2 Pt 1), 538-551.
26. Ghosh S., Mendoza T., Ortiz L.A., Hoyle G.W., Fermin C.D., Brody A.R., Friedman M. and Morris G.F. (2002). Bleomycin sensitivity of mice expressing dominant-negative p53 in the lung epithelium. Am. J. Respir. Crit. Care Med. 166, 890-897.
27. Giri S.N., Hyde D.M. and Hollinger M.A. (1993). Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 48, 959-966.
28. Gressner A.M., Lahme B., Mannherz H.G. and Polzar B. (1997). TGF-beta-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J. Hepatol. 26, 1079-1092.
29. Guinee D. Jr., Fleming M., Hayashi T., Woodward M., Zhang J., Walls J., Koss M., Ferrans V. and Travis W. (1996). Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. Am. J. Pathol. 149, 531-538.
30. Haddad I.Y., Pataki G., Hu P., Galliani C., Beckman J.S. and Matalon S. (1994). Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest. 94, 2407-2413.
31. Haddad I.Y., Ischiropoulos H., Holm B.A., Beckman J.S., Baker J.R. and Matalon S. (1993). Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am. J. Physiol. 265, L555-564.
32. Hadden H.L. and Henke C.A. (2000). Induction of lung fibroblast apoptosis by soluble fibronectin peptides. Am. J. Respir. Crit. Care Med. 162, 1553-1560.
33. Hagimoto N., Kuwano K., Nomoto Y., Kunitake R. and Hara N. (1997a). Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 16, 91-101.
34. Hagimoto N., Kuwano K., Miyazaki H., Kunitake R., Fujita M., Kawasaki M., Kaneko Y. and Hara N. (1997b). Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell Mol. Biol. 17, 272-278.
35. Hagimoto N., Kuwano K., Kawasaki M., Yoshimi M., Kaneko Y., Kunitake R., Maeyama T., Tanaka T. and Hara N. (1999). Induction of interleukin-8 secretion and apoptosis in bronchiolar epithelial cells by Fas ligation. Am. J. Respir. Cell Mol. Biol. 21, 436-445.
36. Hagimoto N., Kuwano K., Inoshima I., Yoshimi M., Nakamura N., Fujita M., Maeyama T. and Hara N. (2002). TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J. Immunol. 168, 6470-6478.
37. Hagiwara S.I., Ishii Y. and Kitamura S. (2000). Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am. J. Respir. Crit. Care Med. 162, 225-231.
38. Haimovitz-Friedman A., Cordon-Cardo C., Bayoumy S., Garzotto M., McLoughlin M., Gallily R., Edwards C.K. 3rd., Schuchman E.H., Fuks Z. and Kolesnick R. (1997). Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 186, 1831-1841.
39. Harrison J.H. Jr., Hoyt D.G. and Lazo J.S. (1989). Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice. Mol. Pharmacol. 36, 231-238.
40. Harrison N.K., Myers A.R., Corrin B., Soosay G., Dewar A., Black C.M., Du Bois R.M. and Turner-Warwick M. (1991). Structural features of interstitial lung disease in systemic sclerosis. Am. Rev. Respir. Dis. 144, 706-713.
41. Hayashi H. Abdollah S., Qiu Y., Cai J., Xu Y.Y., Grimmell B.W., Richardson M.A., Topper J.N., Gimbrone M.A., Wrana J.L. and Falb D. (1997). The MAD-related protein Smad 7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89, 1165-1173.
42. Heldin C.H., Miyazono K. and Dijke P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
43. Henke C., Bitterman P.B., Roongta U., Ingbar D. and Polunovsky V. (1996). Induction of fibroblast apoptosis by anti-CD44 antibody: implications for the treatment of fibroproliferative lung disease. Am. J. Pathol. 149, 1639-1650.
44. Henke C., Marineili W., Jessurun J., Fox J., Harms D., Peterson M., Chiang L. and Doran P. (1993). Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. Am. J. Pathol. 143, 1189-1199.
45. Hiromatsu T., Yajima T., Matsuguchi T., Nishimura H., Wajjwalku W., Arai T., Nimura Y. and Yoshikai Y. (2003). Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis. J. Infect. Dis. 187, 1442-1451.
46. Hodge S., Hodge G., Flower R., Reynolds P.N., Scicchitano R. and Holmes M. (2002). Up-regulation of production of TGF-beta and IL-4 and down-regulation of IL-6 by apoptotic human bronchial epithelial cells. Immunol. Cell Biol. 80, 537-543.
47. Hsu H., Huang J., Shu H.B., Baichwal V. and Goeddel D.V. (1996). TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396.
48. Hsu H., Xiong J. and Goeddel D.V. (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transcluction pathways. Cell 84, 299-308.
49. Hsu H., Xiong J. and Goeddel D.V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-kB activation. Cell 81, 495-504.
50. Hubbert N.L., Sedman S.A. and Schiller J.T. (1992). Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. J. Virol. 66, 6237-6241.
51. Hung W.C., Chang H.C. and Chuang L.Y. (1998). Transforming growth factor beta 1 potently activates CPP32-like proteases in human hepatoma cells. Cell Signal. 10, 511-515.
52. Inoue Y., King T.E. Jr., Tinkle S.S., Dockstader K. and Newman L.S. (1996). Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders. Am. J. Pathol. 149, 2037-2054.
53. Ischiropoulos H., Zhu L. and Beckman J.S. (1992). Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298, 446-451.
54. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hass A., Seto Y. and Nagata S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
55. Ju S.T., Panka D.J., Cui H., Ettinger R., El-Khatib M., Sherr D.H., Stanger B.Z. and Rothstein A.M. (1995). Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444-448.
56. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B. and Craig R.W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311.
57. Kawasaki M., Kuwano K., Hagimoto N., Matsuba T., Kunitake R., Tanaka T., Maeyama T. and Hara N. (2000). Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. Am. J. Pathol. 157, 597-603.
58. Keane M.P., Belperio J.A., Arenberg D.A., Burdick M.D., Xu Z.J., Xue Y.Y. and Strieter R.M. (1999). IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J. Immunol. 163, 5686-5692.
59. Keane M.P., Belperio J.A., Moore T.A., Moore B.B., Arenberg D.A., Smith R.E., Burdick M.D., Kunkel S.L. and Strieter R.M. (1999). Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J. Immunol. 162, 5511-5518.
60. Khalil N., O'Connor R.N., Unruh H.W., Warren P.W., Flanders K.C., Kemp A., Bereznay O.H. and Greenberg A.H. (1991). Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5, 155-162.
61. Kim J.W., Kim H.S., Kim I.K., Kim M.R., Cho E.Y., Kim H.K., Lee J.M. and Namkoong S.E. (1998). Transforming growth factor-beta 1 induces apoptosis through down- regulation of c-myc gene and overexpression of p27Kip1 protein in cervical carcinoma. Gynecol. Oncol. 69, 230-236.
62. King T.E. Jr., Schwarz M.I., Brown K., Tooze J.A., Colby T.V., Waldron J.A., Flint A., Thurlbeck W. and Cherniack R.M. (2001). Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am. J. Respir. Crit. Care Med. 164, 1025-1032.
63. Kitamura Y., Hashimoto S., Mizuta N., Kobayashi A., Kooguchi K., Fujiwara I. and Nakajima H. (2001). Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am. J. Respir. Crit. Care Med. 163(3 Pt 1), 762-769.
64. Ko L.J. and Prives C. (1996). p53: puzzle and paradigm. Genes Dev. 10: ∫π 1054-1072.
65. Kolb M., Margetts P.J., Galt T., Sime P.J., Xing Z., Schmidt M. and Gauldie J. (2001). Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am. J. Respir. Crit. Care Med. 163, 770-777.
66. Kooy N.W., Royall J.A., Ye Y.Z., Kelly D.R. and Beckman J.S. (1995). Evidence for in vivo peroxynitrite production in human acute lung injury. Am. J. Respir. Crit. Care Med. 151, 1250-1254.
67. Korfhagen T.R., Swantz R.J., Wert S.E., McCarty JM., Kerlakian CB., Glasser S.W. and Whitsett J.A. (1994). Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. J. Clin. Invest. 93, 1691-1699.
68. Kroemer G. and Reed J.C. (2000). Mitochondrial control of cell death. Nat. Med. 6, 513-519.
69. Kuwano K., Kunitake R., Kawasaki M., Nomoto Y., Hagimoto N., Nakanishi Y. and Hara N. (1996). P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 154, 477-483.
70. Kuwano K., Miyazaki H., Hagimoto N., Kawasaki M., Fujita M., Kunitake R., Kaneko Y. and Hara N. (1999a). The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am. J. Respir. Cell Mol. Biol. 20, 53-60.
71. Kuwano K., Hagimoto N., Kawasaki M., Yatomi T., Nakamura N., Nagata S., Suda T., Kunitake R., Maeyama T. and Hara N. (1999b). Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest. 104, 13-19.
72. Kuwano K., Kawasaki M., Maeyama T., Hagimoto N., Nakamura N., Shirakawa K. and Hara N. (2000a). Soluble form of fas and fas ligand in BAL fluid from patients with pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia. Chest 118, 451-458.
73. Kuwano K., Kunitake R., Maeyama T., Hagimoto N., Kawasaki M., Matsuba T., Yoshimi M., Inoshima I., Yoshida K. and Hara N. (2001). Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L316-325.
74. Kuwano K., Hagimoto N., Maeyama T., Fujita M., Yoshimi M., Inoshima I., Nakashima N., Hamada N., Watanabe K. and Hara N. (2002). Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias. Lab. Invest. 82, 1695-1706.
75. Lavrentiadou S.N., Chan C., Kawcak T., Ravid T., Tsaba A., van der Vliet A., Rasooly R. and Goldkorn T. (2001). Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione. Am. J. Respir. Cell Mol. Biol. 25, 676-684.
76. Li R., Waga S., Hannon G.J., Beach D. and Stillman B. (1994). Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371, 534-537.
77. Li X., Zhang H., Soledad-Conrad V., Zhuang J. and Uhal B.D. (2003). Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L501-507.
78. Liu J.Y., Brass D.M., Hoyle G.W. and Brody A.R. (1998). TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am. J. Pathol. 153, 1839-1847.
79. Lu Y., Yamagishi N., Yagi T. and Takebe H. (1998). Mutated p21 (WAF1/CIP1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells. Oncogene 16, 705-712.
80. Madtes D.K., Busby H.K., Strandjord T.P. and Clark J.G. (1994). Expression of transforming growth factor-alpha and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. Am. J. Respir. Cell Mol. Biol. 11, 540-551.
81. Maeda J., Ueki N., Hada T. and Higashino K. (1995). Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease. Am. J. Respir. Crit. Care Med. 152, 1587-1591.
82. Maki C.G. and Howley P.M. (1997). Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol. Cell Biol. 17, 355-363.
83. Malinin N.L., Boldin M.P., Kovalenko A.V. and Wallach D. (1997). MAP3K-related kinase involved in NF-κB induction by TNF, CD95, and IL-1. Nature 385, 540-544.
84. Maltzman W. and Czyzyk L. (1984). UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell Biol. 4, 1689-1694.
85. Marshall R.P., McAnulty R.J. and Laurent G.J. (2000). Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am. J. Respir. Crit. Care Med. 160, 1999-2004.
86. Mason R.J. and Shannon J.M. (1997). Alveolar type II cells. In: The lung: scientific foundations. Crystal R.G. (ed). Lippincot-Raven Publishers. Philadelphia.
87. Mason R.J., Leslie C.C., McCormick-Shannon K., Deterding R.R., Nakamura T., Rubin J.S. and Shannon J.M. (1994). Hepatocyte growth factor is a growth factor for rat alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 11, 561-567.
88. Matute-Bello G., Liles W.C., Frevert C.W., Nakamura M., Ballman K., Vathanaprida C., Kiener P.A. and Martin T.R. (2001). Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L328-335.
89. Matute-Bello G., Winn R.K., Jonas M., Chi E.Y., Martin T.R. and Liles W.C. (2001a). Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am. J. Pathol. 158, 153-161.
90. Matute-Bello G., Frevert C.W., Liles W.C., Nakamura M., Ruzinski J.T., Ballman K., Wong V.A., Vathanaprida C. and Martin T.R. (2001b). Fas/Fas ligand system mediates epitheliall injury, but not pulmonary host defenses, in response to inhaled bacteria. Infect. Immun. 69, 5768-5776.
91. Matute-Bello G., Liles W.C., Steinberg K.P., Kiener P.A., Mongovin S., Chi E.Y., Jonas M. and Martin T. R. (1999). Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J. Immunol. 163, 2217-2225.
92. McGrath-Morrow S.A. and Stahl J. (2001). Apoptosis in neonatal murine lung exposed to hyperoxia. Am. J. Respir. Cell Mol. Biol. 25, 150-155.
93. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A. and Rao A. (1997). IKK-1 and IKK-2: cytokine-activated IkB kinases essential for NFκB activation. Science 278, 860-866.
94. Meyer A., Buhl R. and Magnussen H. (1994). The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur. Respir. J. 7, 431-436.
95. Mishra A., Doyle N.A. and Martin W.J. (2000). Bleomycin-mediated pulmonary toxicity: evidence for a p53-mediated response. Am. J. Respir. Cell Mol. Biol. 22, 543-549.
96. Miyazaki Y., Araki K., Vesin C., Garcia I., Kapanci Y., Whitsett J.A., Piguet P.F. and Vassalli P. (1995). Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J. Clin. Invest. 96, 250-259.
97. Molteni A., Ward W.F., Ts'ao, C.H., Solliday N.H. and Dunne M. (1985). Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine. Proc. Soc. Exp. Biol. Med. 180, 112-120..
98. Montuschi P., Ciabattoni G., Paredi P., Pantelidis P., du Bois R.M., Kharitonov S.A. and Barnes P.J. (1998). 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am. J. Respir. Crit. Care Med. 158, 1524-1527.
99. Moodley Y.P., Scaffidi A.K., Misso N.L., Keerthisingam C., McAnulty R.J., Laurent G.J., Mutsaers S.E., Thompson P.J. and Knight D.A. (2003). Fibroblasts isolated from normal lungs and those with Idiopathic pulmonary fibrosis differ in literleukin-6/gp130-mediated cell signaling and proliferation. Am. J. Pathol. 163, 345-354.
100. Nagahori T., Dohi M., Matsumoto K., Saitoh K., Honda Z., Nakamura T. and Yamamoto K. (1999). Interferon-gamma upregulates the c-Met/hepatocyte growth factor receptor expression in alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 21, 490-497.
101. Nakao A., Afrakhte M., Moren A., Nakayama T., Christian JL., Heuchel R., Itoh S., Kawabata M., Heldin N.E., Heldin C.H. and ten Dijke P. (1997). Identification of Smad7, a TGF beta-inducible antagonist of TGF-beta signalling. Nature 1997, 389, 631-635.
102. Nakao A., Fujii M., Matsumura R., Kumano K., Saito Y., Miyazono K. and Iwamoto I. (1999). Transient gene transfer and expression of Smad 7 prevents bleomycin-induced lung fibrosis in mice. J. Clin. Invest. 104, 5-11.
103. Ohtsuka Y., Munakata M., Ukita H., Takahashi T., Satoh A., Homma Y. and Kawakami Y. (1995). Increased susceptibility to silicosis and TNF-alpha production in C57BL/6J mice. Am. J. Respir. Crit. Care Med. 152, 2144-2149.
104. O'Reilly M.A, Staversky R.J, Watkins R.H., Reed C.K., de Mesy Jensen K.L., Finkelstein J.N. and Keng P.C. (2001). The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. Am. J. Respir. Cell Mol. Biol. 24, 703-710.
105. Ortiz L.A., Lasky J., Lungarella G., Cavarra E., Martorana P., Banks W.A., Peschon J.J., Schmidts H.L., Brody A.R. and Friedman M. (1999). Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice. Am. J. Respir. Cell Mol. Biol. 20, 825-833.
106. Otterbein L.E., Kolls J.K., Mantell L.L., Cook J.L., Alam J. and Choi A.M. (1999). Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J. Clin. Invest. 103, 1047-1054.
107. Otterbein L.E., Mantell L.L. and Choi A.M. (1999). Carbon monoxide provides protection against hyperoxic lung injury. Am. J. Physiol. 276, L688-694.
108. Ozdulger A., Cinel I., Koksel O., Cinel L., Avlan D., Unlu A., Okcu H., Dikmengil M. and Oral U. (2003). The protective effect of n-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock 19, 366-372.
109. Panos R.J., Rubin J.S., Csaky K.G., Aaronson S.A. and Mason R.J. (1993). Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J. Clin. Invest. 92, 969-977.
110. Peao M.N., Aguas A.P., de Sa C.M. and Grande N.R. (1994). Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat. Rec. 238, 57-67.
111. Piguet P.F. and Vesin C. (1994). Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur. Respir. J. 7, 515-518.
112. Piguet P.F., Collart M.A., Grau G.E., Sappino A.P. and Vassalli P. (1990). Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344, 245-247.000
113. Piguet P.F., Ribaux C., Karpuz V., Grau G.E. and Kapanci Y. (1993). Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am. J. Pathol. 143, 651-655.
114. Pober J.S and Cotran R.S. (1990). The role of endothelial cells in inflammation. Transplantation 50, 537-544.
115. Polunovsky V.A., Chen B., Henke C., Snover D., Wendt C., Ingbar D.H. and Bitterman P.B. (1993). Role of mesenchymal cell death in lung remodeling after injury. J. Clin. Invest. 92, 388-397.
116. Raghow B., Irish P. and Kang A.H. (1989). Coordinate regulation of transforming growth factor beta gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J. Clin. Invest. 84, 1836-1842.
117. Rahman I., Skwarska E., Henry M., Davis M., O'Connor C.M., FitzGerald M.X., Greening A. and MacNee W. (1999). Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radic. Biol. Med. 27, 60-68.
118. Ray P., Devaux Y., Stolz D.B., Yarlagadda M., Watkins S.C., Lu Y., Chen L., Yang X.F. and Ray A. (2003). Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia. Proc. Natl. Acad. Sci. USA 100, 6098-6103.
119. Regnier C.H., Song H.Y., Gao X., Rothe M. and Goeddel D. (1997). Identification and characterization of an IkB kinase. Cell 90, 373-383.
120. Rom W.N., Basset P., Fells G.A., Nukiwa T., Trapnell B.C. and Crysal R.G. (1988). Alveolar macrophages release an insulin-like growth factor I-type molecule. J. Clin. Invest. 82, 1685-1693.
121. Sakai T., Satoh K., Matsushima K., Shindo S., Abe S., Abe T., Motomiya M., Kawamoto T., Kawabata Y., Nakamura T. and Nukiwa T. (1997). Hepatocyte growth factor in bronchoalveolar lavage fluids and cells in patients with inflammatory chest diseases of the lower respiratory tract: detection by RIA and in situ hybridization. Am. J. Respir. Cell Mol. Biol. 16, 388-397.
122. Saleh D., Barnes P.J. and Giaid A. (1997). Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 155, 1763-1769.
123. Saltzman A., Munro R., Searfoss G., Franks C., Jaye M. and Ivashchenko Y. (1998). Transforming growth factor-beta-mediated apoptosis in the Ramos B- lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation. Exp. Cell Res. 242, 244-254.
124. Shi X., Ding M., Chen F., Wang L., Rojanasakul Y., Vallyathan V. and Castranova V. (2001). Reactive oxygen species and molecular mechanism of silica-induced lung injury. J. Environ. Pathol. Toxicol. Oncol. 20 (Suppl 1), 85-93.
125. Shiratori M., Michalopoulos G., Shinozuka H., Singh G., Ogasawara H. and Katyal S.L. (1995). Hepatocyte growth factor stimulates DNA synthesis in alveolar epithelial type II cells in vitro. Am. J. Respir. Cell Mol. Biol. 12, 171-180.
126. Sime P.J., Xing Z., Graham F.L., Csaky K.G. and Gauldie J. (1997). Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J. Clin. Invest. 100, 768-776.
127. Staversky R.J., Watkins R.H., Wright T.W., Hernady E., LoMonaco M.B., D'Angio C.T., Williams J.P., Maniscalco W.M. and O'Reilly M.A. (2002). Normal remodeling of the oxygen-injured lung requires the cyclin-dependent kinase inhibitor p21(Cip1/WAF1/Sdi1). Am. J. Pathol. 161, 1383-1393.
128. Stehlik C., de Martin R., Kumabashiri I., Schmid J.A., Binder B.R. and Lipp J. (1998). Nuclear factor (NF) -κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J. Exp. Med. 188, 211-216.
129. Suda T., Takahashi T., Golstein T. and Nagata S. (1993). Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169-1178.
130. Sugahara K., Iyama K., Kuroda M.J. and Sano K. (1998). Double intratracheal instillation of keratinocyte growth factor prevents bleomycin-induced lung fibrosis in rats. J. Pathol. 186, 90-98.
131. Suzuki A., Tsutomi Y., Akahane K., Araki T. and Miura M. (1998). Resistance to Fas-mediated apoptosis: activation of caspase-3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 17, 931-939.
132. Suzuki A., Tsutomi Y., Miura M. and Akahane K. (1999). Caspase-3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21. Oncogene 18, 1239-1244.
133. Takahashi T., Tanaka M., Brannan C.I., Jenkins N.A., Copeland N.G., Suda T. and Nagata S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
134. Tan A., Levrey H., Dahm C., Polunovsky V.A., Rubins J. and Bitterman P.B. (1999). Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorders. Am. J. Respir. Crit. Care Med. 159, 220-227.
135. Tartaglia L.A. and Goeddel D.V. (1992). Two TNF receptors. Immunol. Today 13, 151-153.
136. Tateda K., Deng J.C., Moore T.A., Newstead M.W., Paine R. 3rd, Kobayashi N., Yamaguchi K. and Standiford T.J. (2003). Hyperoxia mediates acute lung injury and increased lethality in murine legionella pneumonia: the role of apoptosis. J. Immunol. 170, 4209-4216.
137. Terzaghi M., Nettesheim P. and Williams M.L. (1978). Repopulation of denuded tracheal grafts with normal, preneoplastic, and neoplastic epithelial cell populations. Cancer Res. 38, 4546-4553.
138. Tounekti O., Pron G., Belehradek J. Jr. and Mir L.M. (1993). Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res. 53, 5462-5469.
139. Tsuburai T., Suzuki M., Nagashima Y., Suzuki S., Inoue S., Hasiba T., Ueda A., Ikehara K., Matsuse T. and Ishigatsubo Y. (2002). Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lung prevents bleomycin-induced pulmonary fibrosis via a Fas-Fas ligand-independent pathway. Hum. Gene Ther. 13, 1945-1960.
140. Uhal B.D., Joshi I., True A.L., Mundle S., Raza A., Pardo A. and Selman M. (1995). Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am. J. Physiol. 269, L819-828.
141. Uhal B.D., Joshi I., Hughes W.F., Ramos C., Pardo A. and Selman M. (1998a). Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lund. Am. J. Physiol. 275, L1192-1199.
142. Uhal B.D., Gidea C., Bargout R., Bifero A., Ibarra-Sunga O., Papp M., Flynn K. and Filippatos G. (1998b). Captopril inhibits apoptosis in human lung epithelial cells: a potential antifibrotic mechanism. Am. J. Physiol. 275, L1013-1017.
143. Uhal B.D., Wang R., Laukka J., Zhuang J., Soledad-Conrad V. and Filippatos G. (2003). Inhibition of amiodarone-induced lung fibrosis but not alveolitis by angiotensin system antagonists. Pharmacol. Toxicol. 92, 81-87.
144. Waga S., Hannon G.J., Beach D. and Stillman B. (1994). The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578.
145. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V. and Baldwin A.S. (1998). NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.
146. Wang R., Ramos C., Joshi I., Zagariya A., Pardo A., Selman M. and Uhal B.D. (1999). Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am. J. Physiol. 277, L1158-1164.
147. Wang Q., Wang Y., Hyde DM., Gotwals P.J., Koteliansky V.E., Ryan S.T. and Giri S.N. (1999). Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters. Thorax. 54, 805-812.
148. Ward W.F., Molteni A., Ts'ao C.H. and Hinz J.M. (1990). Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int. J. Radiat. Oncol. Biol. Phys. 19, 1405-1409.
149. Ward N.S., Waxman A.B., Homer R.J., Mantell L.L., Einarsson O., Du Y. and Elias J.A. (2000). Interleukin-6-induced protection in hyperoxic acute lung injury. Am. J. Respir. Cell Mol. Biol. 22, 535-542.
150. Ward W.F., Solliday N.H., Molteni A. and Port C.D. (1983). Radiation injury in rat lung. II. Angiotensin-converting enzyme activity. Radiat. Res. 96, 294-300.
151. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., and Nagata S. (1992). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
152. Waxman A.B., Einarsson O., Seres T., Knickelbein R.G., Warshaw J.B., Johnston R., Homer R.J. and Elias J.A. (1998). Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J. Clin. Invest. 101, 1970-1982.
153. Wendt C.H., Polunovsky V.A., Peterson M.S., Bitterman P.B. and Ingbar D.H. (1994). Alveolar epithelial cells regulate the induction of endothelial cell apoptosis. Am. J. Physiol. 267, C893-900.
154. Witschi H.R., Haschek W.M., Klein-Szanto A.J. and Hakkinen P.J. (1981). Potentiation of diffuse lung damage by oxygen: determining variables. Am. Rev. Respir. Dis. 123, 98-103.
155. Woronicz J.D., Gao X., Cao Z., Rothe M. and Goeddel D. (1997). IκB kinase-b: NFκB activation and complex formation with IB kinase-α and NIK. Science 278, 866-869.
156. 2 exposure. Am. J. Physiol. 275, L780-787.
157. Yaekashiwa M., Nakayama S., Ohnuma K., Sakai T., Abe T., Satoh K., Matsumoto K., Nakamura T., Takahashi T. and Nukiwa T. (1997). Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am. J. Respir. Crit. Care Med. 156, 1937-1944.
158. Yanagisawa K., Osada H., Masuda A., Kondo M., Saito T., Yatabe Y., Takagi K. and Takahashi T. (1998). Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells. Oncogene 17, 1743-1747.
159. Yanagihara K. and Tsumuraya M. (1992). Transforming growth factor beta 1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res. 52, 4042-4045.
160. Yan Q. and Sage E.H.. (1998). Transforming growth tactor-beta1 induces apoptotic cell death in cultured retinal endothelial cells but not pericytes: association with decreased expression of p21waf1/cip1. J. Cell Biochem. 70, 70-83.
161. Yu Z.K., Geyer R.K. and Maki C.G. (2000). MDM2-dependent ubiquitination of nuclear and cytoplasmic P53. Oncogene. 19, 5892-5897.
162. Zandi E., Rothwart D.M., Delhase M., Hayakawa M. and Karin M. (1997). The IκB kinase complex (IKK) contains two kinase subunits, IKKa and IKKb, necessary for IkB phosphorylation and NFκB activation. Cell 91, 243-252.
163. Zhang X., Shan P., Otterbein L.E., Alam J. Flavell R.A., Davis R.J., Choi A.M. and Lee P.J. (2003). Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J. Biol. Chem. 278, 1248-1258.
164. Zhao J., Shi W., Wang Y.L., Chen H., Bringas P. Jr., Datto M.B., Frederick J.P., Wang X.F. and Warburton D. (2002). Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 282, L585-593.